AKT1 and prostate carcinoma: Instead, overexpression of Akt3 in a genetic model of PDGF-driven murine glioma [8] or of the clinically relevant activating mutation Akt1-E17K in murine prostate cancer cells facilitated the repair of radiation-induced DNA damage, thereby increasing radiation resistance [23].